This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Brian Vastag

JAMA. 2001;286:1303-1304.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Washington—If President George W. Bush signs into law some compromise version of the Patients' Bill of Rights, one provision in both the House and Senate bills as JAMA went to press would provide clinical research with a much-needed boost: mandatory insurance coverage of the so-called routine costs of care for patients in clinical trials.

For a decade, cancer care advocates and other patient advocacy groups have been pushing for the rule. They argue that denying usual care to patients because they choose to aid research is not only unfair but inhumane. And while many insurance companies already pay for such costs, patients usually believe that if they join a trial, they will be hit with extra fees.

Passage of the rights bill, awaiting reconciliation of Senate and House versions, would be a clear, hard-earned victory for care advocates as well as patients. And because the clinical trials . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?